201 related articles for article (PubMed ID: 10549452)
1. Acceptability of two spermicides in five countries.
Raymond E; Alvarado G; Ledesma L; Diaz S; Bassol S; Morales E; Fernandez V; Carlos G
Contraception; 1999 Jul; 60(1):45-50. PubMed ID: 10549452
[TBL] [Abstract][Full Text] [Related]
2. Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
Mauck C; Glover LH; Miller E; Allen S; Archer DF; Blumenthal P; Rosenzweig A; Dominik R; Sturgen K; Cooper J; Fingerhut F; Peacock L; Gabelnick HL
Contraception; 1996 Jun; 53(6):329-35. PubMed ID: 8773419
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of five nonoxynol-9 spermicides.
Raymond EG; Chen PL; Condon S; Luoto J; Barnhart KT; Creinin MD; Poindexter A; Wan L; Martens M; Schenken R; Blackwell R
Contraception; 2005 Jun; 71(6):438-42. PubMed ID: 15914133
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of Neo Sampoon, Ortho Vaginal Tablets and Emko Vaginal Tablets in Accra, Ghana.
Lamptey P; Klufio C; Smith SC; Feldblum PJ
Contraception; 1985 Nov; 32(5):445-54. PubMed ID: 3002720
[TBL] [Abstract][Full Text] [Related]
5. Spermicides with N-9 focus of clinical trial.
Contracept Technol Update; 1999 Jan; 20(1):5-6. PubMed ID: 12349021
[TBL] [Abstract][Full Text] [Related]
6. New spermicide: FHI developing propranolol.
Netw Res Triangle Park N C; 1986; 7(2):2-3. PubMed ID: 12340619
[TBL] [Abstract][Full Text] [Related]
7. Contraceptive effectiveness of two spermicides: a randomized trial.
Raymond E; Dominik R
Obstet Gynecol; 1999 Jun; 93(6):896-903. PubMed ID: 10362151
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt.
Youssef H; Crofton VA; Smith SC; Siemens AJ
Contraception; 1987 Feb; 35(2):101-10. PubMed ID: 3297482
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two vaginal tablets: FHI findings mixed.
Netw Res Triangle Park N C; 1983 Sep; 4(4):5. PubMed ID: 12279631
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial.
Raymond EG; Chen PL; Luoto J;
Obstet Gynecol; 2004 Mar; 103(3):430-9. PubMed ID: 14990402
[TBL] [Abstract][Full Text] [Related]
11. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9.
Mauck CK; Allen S; Baker JM; Barr SP; Abercrombie T; Archer DF
Contraception; 1997 Aug; 56(2):103-10. PubMed ID: 9315419
[TBL] [Abstract][Full Text] [Related]
13. Vaginal contraceptives: worldwide use remains low but methods have potential.
Netw Res Triangle Park N C; 1986; 7(2):1, 5. PubMed ID: 12340618
[TBL] [Abstract][Full Text] [Related]
14. Comparative spermicidal performance of iodinated and non-iodinated contraceptive formulations of nonoxynol-9 co-precipitated with polyvinylpyrrolidone.
Zavos PM; Correa JR; Nosek D; Mohammadi F; Digenis GA
Contraception; 1996 Jul; 54(1):39-41. PubMed ID: 8804807
[TBL] [Abstract][Full Text] [Related]
15. Barrier contraceptive use and HIV infection among high-risk women in Cameroon.
Zekeng L; Feldblum PJ; Oliver RM; Kaptue L
AIDS; 1993 May; 7(5):725-31. PubMed ID: 8391273
[TBL] [Abstract][Full Text] [Related]
16. Nonprescription vaginal contraception.
Edelman DA
Int J Gynaecol Obstet; 1980; 18(5):340-4. PubMed ID: 6110578
[TBL] [Abstract][Full Text] [Related]
17. Spermicide used alone for contraception.
Grimes DA; Lopez LM; Raymond EG; Halpern V; Nanda K; Schulz KF
Cochrane Database Syst Rev; 2013 Dec; (12):CD005218. PubMed ID: 24307556
[TBL] [Abstract][Full Text] [Related]
18. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
[TBL] [Abstract][Full Text] [Related]
19. Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia.
Hira SK; Spruyt AB; Feldblum PJ; Sunkutu MR; Glover LH; Steiner MJ
Am J Public Health; 1995 Aug; 85(8 Pt 1):1098-103. PubMed ID: 7625503
[TBL] [Abstract][Full Text] [Related]
20. Polyurethane contraceptive vaginal sponge: product modifications resulting from user experience.
Aznar R; Zamora G; Lozano M; Levi C
Contraception; 1981 Sep; 24(3):235-44. PubMed ID: 7030612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
